Efficacy of Nadolol Alone and Combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension

Title:
Efficacy of Nadolol Alone and Combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension
Creator:
Veterans Administration Cooperative Study Group on Antihypertensive Agents
Date:
1 December 1983
Description:
In this article, the Veterans Administration Cooperative Study Group reported that nadolol, a beta-blocker, and bendroflumethiazide, a diuretic, appeared to be safe and effective antihypertensive agents with minimal side effects. They noted that nadolol was more effective in white patients, while bendroflumethiazide worked better in black patients.
Periodical:
The American Journal of Cardiology
Publisher:
Technical Publishing Company
Location:
Box: 7. Folder: 18
Rights:
Public Domain
Genre:
Articles
Subject:
Hypertension, Antihypertensive Agents, Nadolol, Hydralazine, and Bendroflumethiazide
Format:
Text
Extent:
8 pages
Language:
English
Legacy Source Citation:
Periodical. Veterans Administration Cooperative Study Group on Antihypertensive Agents. "Efficacy of Nadolol Alone and Combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension." The American Journal of Cardiology 52, (1 December 1983): 1230-1237. Article. 8 Images.. The American Journal of Cardiology
Legacy ID:
XFBBFV
NLM ID:
101584929X79
Profiles Collection:
The Edward D. Freis Papers
Shareable Link:
https://profiles.nlm.nih.gov/101584929X79
Story Section:
After 1980: Changing Trends in Hypertension Therapy